跳至内容
首页新闻加州投资 2,600 万美元满足药物使用障碍治疗需求并挽救生命

加州投资 2600 万美元解决物质使用障碍治疗需求并挽救生命

拨款将建立社区伙伴关系并增加治疗机会

SACRAMENTO — The Department of Health Care Services (DHCS) has awarded $26 million to more than 70 organizations to combat the opioid crisis in California. These grants are designed to expand access to treatment, strengthen community partnerships, and save lives. The grants represent a critical part of the State’s Opioid Response (SOR) initiative.

“Addressing the opioid crisis requires a comprehensive, compassionate, and community-driven approach. That’s why DHCS is pleased to partner with so many organizations to offer access to this life-changing care,” said DHCS Director Michelle Baass. “We must expand access to treatment, invest in prevention, and dismantle the stigma surrounding addiction. Lives are at stake, and we are committed to doing everything we can to support recovery.”

减少部落社区未满足的需求和阿片类药物相关的过量用药: DHCS 向12 个组织拨款 210 万美元,用于实施 SOR IV 部落地方阿片类药物联盟 (TLOC) 计划。TLOC 通过增加治疗机会、提供植根于文化的康复服务以及通过预防和护理减少过量用药相关的死亡,为部落和城市印第安人社区提供支持。该计划通过建立社区成员、利益相关者和服务提供者之间的伙伴关系,加强对阿片类药物和兴奋剂使用障碍的康复工作。

“DHCS is pleased to support Tribal communities with resources that reflect their unique needs and strengths. The TLOC program empowers local partnerships to expand treatment, prevent substance use, and promote culturally grounded healing,” said Baass.

EXPANDING ACCESS TO MEDICATIONS FOR ADDICTION TREATMENT: DHCS also awarded nearly $3 million to four DHCS-licensed Narcotic Treatment Programs (NTP) to create satellite facilities, called medication units, that provide access to addiction treatment. These medication units will serve people who otherwise struggle to access care, including people in rural areas, justice-involved communities, and people without reliable transportation, and support care integration.

“Geographically isolated communities often face compounded challenges to accessing care, including transportation barriers and systemic inequities. Establishing medication units addresses these gaps by improving access, enhancing retention, and advancing health equity in the areas that need it most,” said Sarah Khawaja-Laljiani, Senior Director of Grants and Patient Services of Pinnacle Treatment Center, a recipient of funding to expand access to Medications for Addiction Treatment (MAT).

“This funding opportunity aligns with our commitment to expanding access to evidence-based treatment in underserved communities, said Evelyn Sosa, Senior Vice President of BayMark Health Services. “This support will help us meet patients where they are, removing barriers to care and improving outcomes for people most at risk of overdose.”

扩大药物治疗服务范围:此外,DHCS 还向59 个获得 DHCS 许可的住宅药物滥用障碍治疗项目拨款超过 2100 万美元,用于启动或扩大针对阿片类药物使用障碍患者的现场循证药物治疗服务。

“As the opioid and fentanyl crisis continues to devastate lives across the country, expanding access to MAT services in residential programs is not only a clinical necessity, but a moral imperative,” said Dr. BJ Davis, Executive Director, Gateway House for Women and Sacramento Recovery House for Men. “This funding allows us to meet people where they are with the full continuum of evidence-based care.”

“我们的客户需要及时获得药物辅助治疗 (MAT) 来控制毒瘾,并开始他们的康复和稳定之旅,”十字路口基金会执行董事、工商管理硕士林赛·珀迪 (Lindsey Purdie)说。“通过与DHCS的合作,我们有机会扩展我们的服务,更好地满足我们所支持的人们的需求。”我们衷心感谢
资金以及持续
合作。为什么这很重要: 2023 年,有 11,359 人死于与药物相关的过量用药。其中,8000例与阿片类药物有关,7000例与芬太尼有关。虽然加州有相当一部分人符合物质使用障碍的标准,但只有一小部分人接受治疗,这通常是由于农村地区难以获得药物辅助治疗 (MAT) 和纳洛酮等服务。

BIGGER PICTURE: These grants are part of DHCS’ Opioid Response, a key element of Governor Newsom’s Master Plan for Tackling the Fentanyl and Opioid Crisis. For more information about opioids and how you can protect yourself and loved ones, visit Opioids.ca.gov, a one-stop shop for Californians seeking resources around prevention and treatment.

###

通讯办公室
(916) 440-7660
DHCSPress@dhcs.ca.gov